Zurich-based startup Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, ...

The new data – from the ARISE trial – found that Cobenfy wasn't statistically better than placebo at improving the widely ...

PE-backed specialty pharma company Kelso Pharma, which recently acquired Italian medical device and pharma company Velit ...

Health and Human Services (HHS) Secretary Robert F Kennedy Jr, who oversees the FDA, has made no secret of his desire to ban ...

Clinical trial success rates are very low, with up to 95% not succeeding, and a wide range of disease states remains ...

For companies in the biotech space, it’s never been easy to navigate the legal and business risks inherent in a highly ...

Enhertu is already approved as a second-line or later therapy for HER2-positive breast cancer based on the results of the ...

At the American Urological Association (AUA) that starts later this week, J&J is scheduled to report that TAR-200 achieved a ...

Sky Labs' CART-I ring – described as a cardio tracker – achieved 84.6% sensitivity compared to 69.1% for the Apple Watch, ...

Roche's decision to invest heavily in the US – along with Novartis' announcement, has come hard on the heels of European ...

The study enrolled patients with a PD-L1 combined positive score (CPS) of 10 or more, matching Keytruda's label in first-line ...

The EU approval comes after Eisai and Biogen were given approval for a new once-monthly intravenous maintenance dose of ...